DIN 02530031 — ZEJULA 100 MG
ZEJULA is a tablet of Niraparib marketed by GLAXOSMITHKLINE INC. The full Niraparib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02530031
- Brand name
- ZEJULA
- Active ingredient
- Niraparib
- Strength
- 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Poly (ADP-ribose) polymerase (PARP) inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Niraparib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02489783 | ZEJULA | 100 MG | CAPSULE | GLAXOSMITHKLINE INC | DORMANT |